Rhonda Hewitt, NP
Nurse Practitioner · Stanford, CANPI 1649289943
Payments from drug & device makers
Across 1,936 payments — averaging $473.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$451K
- Amgen$125K
- AstraZeneca$89K
- Incyte Corporation$74K
- Pharmacyclics LLC, An Abbvie Company$65K
- Beone Medicines USA, Inc.$26K
- plus $89K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 875 | $450,584 |
| Amgen | 294 | $124,859 |
| AstraZeneca | 153 | $88,909 |
| Incyte Corporation | 196 | $73,630 |
| Pharmacyclics LLC, An Abbvie Company | 141 | $64,632 |
| Beone Medicines USA, Inc. | 46 | $25,632 |
| Beigene USA, Inc. | 39 | $22,419 |
| GSK | 37 | $22,188 |
| Adaptive Biotechnologies Corporation | 26 | $12,480 |
| Servier Pharmaceuticals LLC | 33 | $12,002 |
| Syndax Pharmaceuticals, Inc. | 22 | $9,734 |
| Sanofi | 7 | $5,166 |
| E.r. Squibb & Sons, L.L.C. | 5 | $1,187 |
| Janssen Global Services, LLC | 1 | $1,060 |
| Bristol Myers Squibb | 4 | $770 |
| AbbVie | 16 | $540 |
| Rigel Pharmaceuticals, Inc. | 7 | $251 |
| Pharmaessentia USA Corporation | 7 | $208 |
| Gilead | 7 | $177 |
| Merck | 5 | $137 |
| Janssen Scientific Affairs, LLC | 2 | $96 |
| Daiichi Sankyo Inc. | 3 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Geron Corporation | 1 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Legend Biotech USA Inc. | 1 | $35 |
| Stemline Therapeutics Inc. | 1 | $29 |
| CTI Biopharma Corp. | 1 | $28 |
| Novartis | 1 | $13 |
How this compares
$917,040 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Stanford
- Hamta ZareStanford$428K
- Theresa Mallick-SearleStanford$193K
- Martina SpeightStanford$170K
- Helen ShihStanford$104K
- Connie WolfordStanford$69K
- Michelle GapayStanford$37K
- Elaine JangStanford$32K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.